share roch list swiss exchang thirdlargest drug compani world could offer excel buy opportun come week european peer updat market cheap copycat drug impact financ share swissbas pharmaceut group could hit peer trade updat show product signific impact copycat longterm investor opportun buy share secur 3pc prospect dividend yield cheap roch key drug face increas competit patent expir compani suffer sharp drop sale drug difficult copi roch specialis biopharmaceut major deriv life form make difficult copi drug base chemic compound roch portfolio drug threat new wave biosimilar copi origin product approv regul europ us biosimilar taken come market requir lengthi clinic trial approv also great increas cost howev new wave biosimilar releas signific impact longterm invest case pharmaceut share april set big month biosimilar newsflow could point sanguin view held mani market start turn sour said naresh chouhan broker liberum market expect new copycat drug price 20pc 30pc discount brand origin mr chouhan believ new drug present substanti risk price point merck arthriti treatment remicad seen price discount 70pc norwegian market follow introduct biosimilar merck announc quarter trade updat april 28 like impact whole pharmaceut sector roch share react compani generat 60pc revenu biopharmaceut current valuat roch share depend earn grow next five year howev wont happen price drug come pressur share like weak next fortnight given threat sale profit forecast biosimilar howev silver liningth compani also world leader cancer treatment excit pipelin new drug final stage clinic trial compani updat market american societi clinic oncolog meet world biggest event cancer research end may upbeat news trial catalyst share recov roch give first quarter updat april 22 classic defens stock solid balanc sheet excel track record generat cash compani like return money investor dividend share list switzerland purchas onlin platform broker dividend paid swiss franc foreign currenc exposur dividend incom incur 15pc withhold tax uk doubl taxat treati swiss still leav share pay prospect dividend yield 26pc payout forecast increas 5pc everi year think share excel longterm invest becom attract take hit rival trade updat later month perfect opportun lock dividend growth 